halneuron
Generic: Tetrodotoxin
halneuron: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | Phase 2 |
Clinical Trials (1)
A Randomized, Double-Blind, Placebo Controlled, Multicenter Study With Optional Open-Label Extension to Evaluate the Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Frequently asked questions
Who is developing halneuron?
halneuron is being developed by Dogwood Therapeutics, Inc..
How many clinical trials involve halneuron?
BioSniper tracks 1 clinical trial involving halneuron.
Get deeper analysis on halneuron
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis